Pulmonology drugs
2 results
Tezspire (tezepelumab-ekko)
(tezepelumab-ekko)Amgen, Inc
Usage: TEZSPIRE is indicated for the add-on maintenance treatment of severe asthma in adults and pediatric patients aged 12 years and older. It is not intended for the relief of acute bronchospasm or status asthmaticus.
Xolair (omalizumab)
(omalizumab)Genentech, Inc.
Usage: XOLAIR is indicated for adults and children 6 years and older with moderate to severe persistent asthma, chronic rhinosinusitis with nasal polyps (adults 18+), IgE-mediated food allergies (ages 1+), and chronic spontaneous urticaria (ages 12+). It is not for acute bronchospasm or emergency allergic reactions.